ArticleBreast cancer research : BCR2025

MAP3K1/MAP2K4 mutations drive breast cancer progression by compensating for TP53 loss through inactivation of the JNK2-p53-FOSL1 axis.

Sike Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.